Gastrointestinal Very common (10% or more): Nausea (up to 18%), diarrhea (up to 17%) Common (1% to 10%): Vomiting, constipation, dyspepsia, abdominal pain, eructation, flatulence, gastroesophageal reflux disease, abdominal distension Uncommon (0.1% to 1%): Cholelithiasis, acute pancreatitis, increased serum pancreatic amylase levels, increased serum lipase levels, acute gallbladder disease (including cholelithiasis, biliary colic and cholecystectomy) Postmarketing reports : Ileus In pooled placebo-controlled trials, treatment with this drug resulted in mean increases from baseline in serum pancreatic amylase levels of up to 38% and serum lipase levels of up to 42%
By losing just 5-7% of body weight and getting regular physical activity, individuals can reduce the risk (or reverse the effects) of many weight-related conditions.[3] Effects of Excess Weight and Obesity Excess weight puts individuals at risk for a number of health conditions including: Heart disease Stroke Kidney disease Eye problems Nerve damage Heart disease Sleep apnea Metabolic syndrome Osteoarthritis Gall bladder disease Some cancers Anxiety Depression Social isolation Gestational diabetes (pregnant women).[12] Weight Management Through SemaglutideGet Slimmer Faster The compound, Semaglutide was initially developed in 2012 as a longer acting treatment for diabetes
In a clinical trial of the Wegovy pill in people without diabetes, people taking a 25 mg dose lost about 6% of their body weight in three months
Ivim Health GLP-1 Medication Options FAQ Spotlight: Is a specific medication or brand guaranteed on Ivim Health
Dosage pricing explanation
